Progressive rash after recent antibiotic exposure.
LeMaster
Christopher H
CH
Harvard Affiliated Emergency Medicine Residency, Division of Emergency Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Brown
David F M
DF
Nadel
Eric S
ES
D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000276:immunology; D002511:Cephalosporins / Q000009:adverse effects / Q000276:immunology; D018450:Disease Progression; D004630:Emergencies; D005076:Exanthema / Q000175:diagnosis / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010406:Penicillins / Q000009:adverse effects / Q000276:immunology; D013449:Sulfonamides / Q000009:adverse effects / Q000276:immunology; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects*; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000175:diagnosis* / Q000209:etiology*
D000890:Anti-Infective Agents; D002511:Cephalosporins; D010406:Penicillins; D013449:Sulfonamides; D015662:Trimethoprim, Sulfamethoxazole Drug Combination